Description
✅Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG (Moxiphar, CV Suspension), Pharma Franchise & Third Party Manufacturing
Biophar Lifesciences offers you Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG (Moxiphar, CV Suspension), a very well-known and trusted antibiotic formulation that is most commonly prescribed for bacterial infections in paediatric patients. This combination medicine is characterised by its broad-spectrum antibacterial action, and it is quite consistently recommended by healthcare professionals for the treatment of paediatric respiratory, urinary, skin, and soft tissue infections.
If you want to have a pharma franchise for Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG and also PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG, then Biophar Lifesciences is the best place to consider for great business opportunities, along with top-notch manufacturing standards and profitable margins.
Product Overview
Product Name: Moxiphar CV Suspension Composition: Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG Dosage Form: Oral Suspension Category: Paediatric Antibiotic
Amoxicillin is a bactericidal antibiotic that kills bacteria by preventing them from forming a cell wall. While potassium clavulanate resists bacteria by keeping amoxicillin active against bacteria that produce the beta-lactamase enzyme, a major way in which bacteria become resistant to antibiotics. This combination makes the formulation highly effective against a wide range of bacterial infections.
✅Benefits of Moxiphar CV Suspension
Generally, Moxiphar CV Suspension is given to children experiencing ear infections, throat infections, bronchitis, sinusitis, urinary tract infections, and skin infections. The suspension version facilitates easy dosage and increased willingness of children to take the medicine.
It is made by following very strict quality control procedures, which comply with IP standards. Besides, to assure safety, purity, and effectiveness, it is done in WHO- and GMP-certified facilities.
Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
Biophar Lifesciences, through its Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG programme, offers a profitable avenue for distributors and medical representatives. Our franchise system is structured to provide our partners with exclusive rights, promotional support, and an uninterrupted supply of products.
The major benefits are:
- Highly demanded paediatric antibiotic
- Attractive promotional inputs
- Competitive pricing
- On-time product delivery
- Strong brand support
The product is very popular in the market and will therefore be a great addition to the pharmaceutical portfolio.
✅PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
The PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG we offer is a great opportunity for individuals and entities wanting to establish themselves in the paediatric sector. As bacterial infection cases keep on increasing, this combination suspension is highly preferred and prescribed from time to time.
Biophar Lifesciences offers marketing materials, sales aids, and business support to its franchise partners for them to be successful even in the most competitive markets.
Third-Party Manufacturing of Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG
Besides the franchise opportunities, we also have third-party manufacturing of Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG at your disposal. Our manufacturing unit, equipped with the latest technology, strictly follows quality assurance procedures and all the safety guidelines of the industry.
We provide:
- Customised packaging solutions
- Bulk manufacturing capabilities
- Private labelling options
- Manufacturing competitive rates
- Production and dispatch on time
Our skilled production staff maintains high-quality ingredients consistently and accurate dosage levels.
🤝 Why Biophar Lifesciences?
Biophar Lifesciences strives to supply the market with quality pharmaceutical products that are backed by innovation and reliability. Facilitated by a strong distribution network and a customer-oriented mindset, we ensure hassle-free partnership and continuous development for our partners.
Should you require a Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG, or a PCD Pharma Franchise Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG, or even a Third Party Manufacturing Amoxicillin and Potassium Clavulanate Oral Suspension IP 228.5 MG, we at Biophar offer full support and high-quality products.
Get in touch with Biophar Lifesciences for all your business enquiries and partnership proposals, and expand, with a guarantee, your pharmaceutical business.
Contact Biophar Lifesciences for any business enquiries and partnership proposals, and increase your pharmaceutical business with assurance.
